GRANT PROGRAM DESCRIPTION
The goal of this grant program is to provide competitive funding for clinical research that encourages the development of new therapies and treatment and adds to the understanding of the principles and practice of clinical toxicology. The intended research should advance the mission of the AACT to unite “scientists and clinicians in the advancement of research, education, prevention and treatment of diseases caused by chemicals, drugs and toxins.” The project may be part of a larger project but must have a specific hypothesis and aims that are separate and distinct.
- The research must focus on clinical toxicology research.
- The principal investigator must be a member of the American Academy of Clinical Toxicology in good standing.
- Multidisciplinary research teams are encouraged.
- The study timeline should not exceed 24 months from project initiation.
FUNDING INFORMATION AND APPLICATION DEADLINE
The next award will be announced in 2017.
One grant, offered every other year, of up to $5,000 is available to fund one study. An additional award of a maximum of $1000 will be provided for travel to the NACCT to present the results of the project. Grants are awarded to provide funding for specific projects that address clinical toxicology research and are not intended for long-term support of research programs.
Funds may not be applied to:
- Ongoing general operating expenses or existing deficits
- Salary support for study personnel
- Purchase of equipment, facilities, or software, or other capital costs
- Facilities and administrative (institutional indirect) costs
Funding is generally available for:
- Consumable supplies and services
- Travel to the NACCT meeting to present the results of the proposed project
- Subject expenses/reimbursement
- Laboratory analysis, statistical analysis and similar activities
GRANT RECIPIENT RESPONSIBILITIES
- The AACT requires that the findings of the funded study be submitted for presentation at a national or international scientific meeting. The North American Congress of Clinical Toxicology retains the right of first refusal for presentation of all findings that emanate from this AACT-sponsored research.
- The AACT encourages investigators to submit the findings of the study to a peer-reviewed journal for publication. Clinical Toxicology retains the right of first refusal for publication of all findings that emanate from this AACT-sponsored research.
By accepting this award, the grantee will undertake all reasonable efforts to complete the study and take responsibility for fulfilling the terms described within the award letter.
Congratulations to the 2017 AACT Research Award Winner: Morgan Riggan, MD
The 2017 AACT Research Award has been granted to Morgan Riggan, MD from the New York City Poison Control Center for her research project entitled “The effects of activated charcoal and polyethylene glycol with electrolyte solution on bupropion XL concentration in vivo”. We are looking forward to seeing the results at NACCT 2018 in Chicago, Illinois!
Congratulations Dr. Riggan!